计算溶液所需的质量、体积或浓度。
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
Q125550-1mg |
1mg |
现货 ![]() |
| |
Q125550-5mg |
5mg |
现货 ![]() |
| |
Q125550-10mg |
10mg |
现货 ![]() |
| |
Q125550-25mg |
25mg |
现货 ![]() |
| |
Q125550-50mg |
50mg |
现货 ![]() |
| |
Q125550-100mg |
100mg |
现货 ![]() |
| |
Q125550-250mg |
250mg |
现货 ![]() |
|
别名 | N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 | N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 | 6-氨基-4-[2-(4-苯氧基苯基)乙氨基]喹唑啉 |
---|---|
英文别名 | EVP-4593 | Curator_000005 | N~4~-[2-(4-Phenoxyphenyl)ethyl]quinazoline-4,6-diamine | EVP4593 | GTPL6012 | BCP07901 | DTXSID00333507 | HMS3652J12 | AC-32085 | 4,6-Quinazolinediamine, N4-[2-(4-phenoxyphenyl)ethyl]- | QNZ(EVP4593) | AMY24212 | FT-0661997 | E |
规格或纯度 | Moligand™, ≥98% |
英文名称 | QNZ (EVP4593) |
生化机理 | QNZ 可抑制转录因子 NF-κB 的活化,已被用于研究 NF-κB 信号转导。NF-κB 的不当激活与癌症、免疫和炎症疾病以及病毒感染有关。研究结果表明,QNZ 能完全阻断大鼠感觉神经元中 K 电流的增加。QNZ 已被用于研究结肠直肠癌和许旺细胞功能。抑制 LPS 诱导的 TNFα 生成(IC 50 = 7 nM)。EVP4593 是一种高亲和力的 NF-KB 通路激活部分拮抗剂,通过抑制贮存操作的钙离子(Ca2+)进入(SOC)发挥作用。EVP4593 似乎以 HD 神经元中含有 TRPC1 作为亚基之一的异构通道为靶标。EVP4593 在纳摩尔浓度下对谷氨酸毒性具有神经保护作用。 |
储存温度 | -20°C储存,充氩 |
运输条件 | 超低温冰袋运输 |
备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
QNZ (EVP4593)有效抑制NF-κB激活和TNF-α产生,IC50分别为11 nM和7 nM。An inhibitor of the transcription factor NFκB. QNZ (EVP4593) 强抑制 NF-κB 转录激活和 TNF-α 产生,IC50 分别为 11 和 7 nM。QNZ (EVP4593) 是一种保护神经的钙池操纵的钙通道 (SOC) 抑制剂。 QNZ (EVP4593)有效抑制NF-κB激活和TNF-α产生,在Jurkat T细胞中IC50分别为11 nM和7 nM。 QNZ (EVP4593) shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM, respectively. |
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504758961 |
---|---|
分子类型 | 小分子 |
IUPAC Name | 4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine |
INCHI | InChI=1S/C22H20N4O/c23-17-8-11-21-20(14-17)22(26-15-25-21)24-13-12-16-6-9-19(10-7-16)27-18-4-2-1-3-5-18/h1-11,14-15H,12-13,23H2,(H,24,25,26) |
InChi Key | IBAKVEUZKHOWNG-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C(C=C1)OC2=CC=C(C=C2)CCNC3=NC=NC4=C3C=C(C=C4)N |
Isomeric SMILES | C1=CC=C(C=C1)OC2=CC=C(C=C2)CCNC3=NC=NC4=C3C=C(C=C4)N |
WGK Germany | 3 |
PubChem CID | 509554 |
分子量 | 356.42 |
溶解性 | Soluble in DMSO (20 mg/ml), DMF (30 mg/ml), ethanol (10 mg/ml), and 1:1 solution DMF:PBS(pH 7.2) (0.5 mg/ml). |
---|---|
敏感性 | 对空气敏感,对热敏感 |
熔点 | 184 °C |
分子量 | 356.400 g/mol |
XLogP3 | 4.700 |
氢键供体数Hydrogen Bond Donor Count | 2 |
氢键受体数Hydrogen Bond Acceptor Count | 5 |
可旋转键计数Rotatable Bond Count | 6 |
精确质量Exact Mass | 356.164 Da |
单同位素质量Monoisotopic Mass | 356.164 Da |
拓扑极表面积Topological Polar Surface Area | 73.100 Ų |
重原子数Heavy Atom Count | 27 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 434.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
象形图 | GHS09, GHS07 |
---|---|
信号词 | Warning |
危险声明 |
H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H413: 可能对水生生物造成长期的有害影响 H302: 吞食有害 H410: 对水生生物有剧毒并具有长期持续影响 |
预防措施声明 |
P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P273: 避免释放到环境中。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P302+P352: 如皮肤沾染:用水充分清洗。 P321: 特殊处理(请参阅此标签上的...)。 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P391: 收集溢出物 P330: 漱口 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 |
WGK Germany | 3 |
Purity(HPLC) | 98-100(%) |
---|---|
Appearance(Q125550) | white to beige to yellow to Green powder to crystal |
NMR spectrum | Conforms to Structure |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
批号(Lot Number) | 证书类型 | 日期 | 货号 |
---|---|---|---|
![]() |
分析证书 | 25-06-18 | Q125550 |
![]() |
分析证书 | 25-06-17 | Q125550 |
![]() |
分析证书 | 24-09-19 | Q125550 |
![]() |
分析证书 | 24-09-19 | Q125550 |
![]() |
分析证书 | 24-09-19 | Q125550 |
![]() |
分析证书 | 24-09-02 | Q125550 |
![]() |
分析证书 | 24-09-02 | Q125550 |
![]() |
分析证书 | 24-09-02 | Q125550 |
![]() |
分析证书 | 24-04-13 | Q125550 |
¥494.32
1. Vossen AC, Savelkoul HF. (1994) Cytokines in clinical and experimental transplantation.. Mediators Inflamm, 3 (6): (403-10). [PMID:18475587] [10.1021/op500134e] |
2. Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H, Fukazawa T, Hayashi H. (2003) Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation.. Bioorg Med Chem, 11 (3): (383-91). [PMID:12517433] [10.1021/op500134e] |
3. Wu J, Shih HP, Vigont V, Hrdlicka L, Diggins L, Singh C, Mahoney M, Chesworth R, Shapiro G, Zimina O et al.. (2011) Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment.. Chem Biol, 18 (6): (777-93). [PMID:21700213] [10.1021/op500134e] |
4. Baeuerle PA, Henkel T. (1994) Function and activation of NF-kappa B in the immune system.. Annu Rev Immunol, 12 (13): (141-79). [PMID:8011280] [10.1021/op500134e] |
5. Baeuerle PA, Baltimore D. (1996) NF-kappa B: ten years after.. Cell, 87 (1): (13-20). [PMID:8858144] [10.1021/op500134e] |
6. Blackwell TS, Christman JW. (1997) The role of nuclear factor-kappa B in cytokine gene regulation.. Am J Respir Cell Mol Biol, 17 (1): (3-9). [PMID:9224203] [10.1021/op500134e] |
7. May MJ, Ghosh S. (1998) Signal transduction through NF-kappa B.. Immunol Today, 19 (2): (80-8). [PMID:9509763] [10.1021/op500134e] |
8. Xi XJ et al.. (2020) Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis.. J Cell Mol Med, 24 (13): (7609-7624). [PMID:32441055] |
9. Qing P & Liu Y. (2020) Inhibitory role of long non-coding RNA OIP5-AS1 in rheumatoid arthritis progression through the microRNA-448-paraoxonase 1-toll-like receptor 3-nuclear factor ?B axis.. Exp Physiol, 105 (10): (1708-1719). [PMID:32770578] |
10. Liu S & Li W. (2020) Prazosin blocks apoptosis of endothelial progenitor cells through downregulating the Akt/NF-?B signaling pathway in a rat cerebral infarction model.. Exp Ther Med, 20 (3): (2577-2584). [PMID:32765751] |
11. Zhu Y et al.. (2020) Protective role of long noncoding RNA CRNDE in myocardial tissues from injury caused by sepsis through the microRNA-29a/SIRT1 axis.. Life Sci, 255 (117849). [PMID:32473249] |
12. Balachandran Y et al.. (2022) Regulation of TLR10 Expression and Its Role in Chemotaxis of Human Neutrophils.. J Innate Immun, 14 (6): (629-642). [PMID:35613551] |